Suppr超能文献

培养中的两栖动物细胞。II. 耐药变体和不依赖天冬酰胺变体的分离。

Amphibian cells in culture. II. Isolation of drug-resistant variants and an asparagine-independent variant.

作者信息

Chinchar G D, Sinclair J H

出版信息

J Cell Physiol. 1978 Sep;96(3):343-54. doi: 10.1002/jcp.1040960310.

Abstract

With L-15 as the base medium, drug-resistant variants were isolated from two amphibian tissue culture strains: the Xenopus laevis A8 diploid cell line and the ICR 2A cell line of Rana pipiens. Four different classes of variants were obtained: (1) A8 cells resistant to chloramphenicol, an inhibitor of mitochondrial protein synthesis; (2) A8 cells resistant to ouabain, an inhibitor of the Na+/K+-activated ATPase of the plasma membrane;(3) ICR 2A cells resistant to low (20 microgram/ml) and high (300 microgram/ml) levels of bromodeoxyuridine (BUdR), a thymidine analog which interferes with the pyrimidine salvage pathway; and (4) ICR 2A cells resistant to 2,6-diaminopurine (DAP), an adenine analog which interferes with the purine salvage pathway. Unlike the other variants, isolation of BUdR resistant cells is a 2-step process. Resistance to low levels of BUdR is phenotypically expressed by a reduction in thymidine transport activities while resistance to high levels of this compound is evidenced by greatly reduced levels of thymidine kinase activity. DAP-resistant cells, which are characterized by reduced levels of adenine phosphoribosyl transferase (APRT) activity, do not die in AAT (adenine, aminopterin, thymidine) selection medium. This suggests that these cells utilize adenine efficiently. With MEM as the base medium, an asparagine independent clone was isolated from the ICR 2A cell line. When compared with the wild type, this variant exhibited a slightly reduced growth rate in the presence or absence of asparagine.

摘要

以L - 15为基础培养基,从两种两栖类组织培养细胞系中分离出耐药变体:非洲爪蟾A8二倍体细胞系和豹蛙ICR 2A细胞系。获得了四类不同的变体:(1)对氯霉素(一种线粒体蛋白质合成抑制剂)耐药的A8细胞;(2)对哇巴因(一种质膜Na⁺/K⁺ - 激活ATP酶的抑制剂)耐药的A8细胞;(3)对低浓度(20微克/毫升)和高浓度(300微克/毫升)溴脱氧尿苷(BUdR,一种干扰嘧啶补救途径的胸苷类似物)耐药的ICR 2A细胞;(4)对2,6 - 二氨基嘌呤(DAP,一种干扰嘌呤补救途径的腺嘌呤类似物)耐药的ICR 2A细胞。与其他变体不同,分离耐BUdR细胞是一个两步过程。对低水平BUdR的耐药性在表型上表现为胸苷转运活性降低,而对该化合物高水平的耐药性则表现为胸苷激酶活性大幅降低。耐DAP细胞的特征是腺嘌呤磷酸核糖转移酶(APRT)活性降低,在AAT(腺嘌呤、氨基蝶呤、胸苷)选择培养基中不会死亡。这表明这些细胞能有效利用腺嘌呤。以MEM为基础培养基,从ICR 2A细胞系中分离出一个不依赖天冬酰胺的克隆。与野生型相比,该变体在有或没有天冬酰胺的情况下生长速率略有降低。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验